Analysts Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $5.02
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year […]
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year […]
